The legacy of Viagra and its impact on the drug landscape presents a intriguing question for shareholders . Initially a massive drug, copycat medications have significantly diminished its market presence , https://tomasjjqq467887.jiliblog.com/98093599/the-blue-pill-and-big-pharma-a-risky-opportunity